Table of Content
1 Introduction
1.1 Objective of the Study
1.2 Definition of the Market
1.3 Market Scope
1.3.1 Market Segment by Type, Application and Marketing Channel
1.3.2 Major Regions Covered (North America, Europe, Asia Pacific, Mid East & Africa)
1.4 Years Considered for the Study (2015-2028)
1.5 Currency Considered (U.S. Dollar)
1.6 Stakeholders
2 Key Findings of the Study
3 Market Dynamics
3.1 Driving Factors for this Market
3.2 Factors Challenging the Market
3.3 Opportunities of the Global Mesalamine Market (Regions, Growing/Emerging Downstream Market Analysis)
3.4 Technological and Market Developments in the Mesalamine Market
3.5 Industry News by Region
3.6 Regulatory Scenario by Region/Country
3.7 Market Investment Scenario Strategic Recommendations Analysis
4 Value Chain of the Mesalamine Market
4.1 Value Chain Status
4.2 Upstream Raw Material Analysis
4.3 Midstream Major Company Analysis (by Manufacturing Base, by Product Type)
4.4 Distributors/Traders
4.5 Downstream Major Customer Analysis (by Region)
5 Global Mesalamine Market-Segmentation by Type
5.1 Capsule
5.2 Tablets
6 Global Mesalamine Market-Segmentation by Application
6.1 Adult
6.2 Children
7 Global Mesalamine Market-Segmentation by Marketing Channel
7.1 Traditional Marketing Channel (Offline)
7.2 Online Channel
8 Competitive Intelligence - Company Profiles
8.1 Lunan Better Pharmaceutical
8.1.1 Lunan Better Pharmaceutical Profile
8.1.2 Lunan Better Pharmaceutical Sales, Growth Rate and Global Market Share from 2015-2020
8.1.3 Lunan Better Pharmaceutical Product/Solution Launches and Enhancements Analysis
8.1.4 Lunan Better Pharmaceutical Business Overview/Recent Development/Acquisitions
8.2 Boehringer Ingelheim
8.2.1 Boehringer Ingelheim Profile
8.2.2 Boehringer Ingelheim Sales, Growth Rate and Global Market Share from 2015-2020
8.2.3 Boehringer Ingelheim Product/Solution Launches and Enhancements Analysis
8.2.4 Boehringer Ingelheim Business Overview/Recent Development/Acquisitions
8.3 Mylan
8.3.1 Mylan Profile
8.3.2 Mylan Sales, Growth Rate and Global Market Share from 2015-2020
8.3.3 Mylan Product/Solution Launches and Enhancements Analysis
8.3.4 Mylan Business Overview/Recent Development/Acquisitions
8.4 Cipla
8.4.1 Cipla Profile
8.4.2 Cipla Sales, Growth Rate and Global Market Share from 2015-2020
8.4.3 Cipla Product/Solution Launches and Enhancements Analysis
8.4.4 Cipla Business Overview/Recent Development/Acquisitions
8.5 Nogra Pharma
8.5.1 Nogra Pharma Profile
8.5.2 Nogra Pharma Sales, Growth Rate and Global Market Share from 2015-2020
8.5.3 Nogra Pharma Product/Solution Launches and Enhancements Analysis
8.5.4 Nogra Pharma Business Overview/Recent Development/Acquisitions
8.6 Salix Pharmaceuticals
8.6.1 Salix Pharmaceuticals Profile
8.6.2 Salix Pharmaceuticals Sales, Growth Rate and Global Market Share from 2015-2020
8.6.3 Salix Pharmaceuticals Product/Solution Launches and Enhancements Analysis
8.6.4 Salix Pharmaceuticals Business Overview/Recent Development/Acquisitions
8.7 AstraZeneca
8.7.1 AstraZeneca Profile
8.7.2 AstraZeneca Sales, Growth Rate and Global Market Share from 2015-2020
8.7.3 AstraZeneca Product/Solution Launches and Enhancements Analysis
8.7.4 AstraZeneca Business Overview/Recent Development/Acquisitions
8.8 Dr Falk Pharma
8.8.1 Dr Falk Pharma Profile
8.8.2 Dr Falk Pharma Sales, Growth Rate and Global Market Share from 2015-2020
8.8.3 Dr Falk Pharma Product/Solution Launches and Enhancements Analysis
8.8.4 Dr Falk Pharma Business Overview/Recent Development/Acquisitions
8.9 Sandoz Mesalamine
8.9.1 Sandoz Mesalamine Profile
8.9.2 Sandoz Mesalamine Sales, Growth Rate and Global Market Share from 2015-2020
8.9.3 Sandoz Mesalamine Product/Solution Launches and Enhancements Analysis
8.9.4 Sandoz Mesalamine Business Overview/Recent Development/Acquisitions
8.10 Takeda
8.10.1 Takeda Profile
8.10.2 Takeda Sales, Growth Rate and Global Market Share from 2015-2020
8.10.3 Takeda Product/Solution Launches and Enhancements Analysis
8.10.4 Takeda Business Overview/Recent Development/Acquisitions
8.11 Janssen (Johnson & Johnson)
8.11.1 Janssen (Johnson & Johnson) Profile
8.11.2 Janssen (Johnson & Johnson) Sales, Growth Rate and Global Market Share from 2015-2020
8.11.3 Janssen (Johnson & Johnson) Product/Solution Launches and Enhancements Analysis
8.11.4 Janssen (Johnson & Johnson) Business Overview/Recent Development/Acquisitions
8.12 Pfizer
8.12.1 Pfizer Profile
8.12.2 Pfizer Sales, Growth Rate and Global Market Share from 2015-2020
8.12.3 Pfizer Product/Solution Launches and Enhancements Analysis
8.12.4 Pfizer Business Overview/Recent Development/Acquisitions
8.13 Cosmo Pharmaceuticals
8.13.1 Cosmo Pharmaceuticals Profile
8.13.2 Cosmo Pharmaceuticals Sales, Growth Rate and Global Market Share from 2015-2020
8.13.3 Cosmo Pharmaceuticals Product/Solution Launches and Enhancements Analysis
8.13.4 Cosmo Pharmaceuticals Business Overview/Recent Development/Acquisitions
8.14 Ferring
8.14.1 Ferring Profile
8.14.2 Ferring Sales, Growth Rate and Global Market Share from 2015-2020
8.14.3 Ferring Product/Solution Launches and Enhancements Analysis
8.14.4 Ferring Business Overview/Recent Development/Acquisitions
8.15 Synmosa Biopharma Corporation
8.15.1 Synmosa Biopharma Corporation Profile
8.15.2 Synmosa Biopharma Corporation Sales, Growth Rate and Global Market Share from 2015-2020
8.15.3 Synmosa Biopharma Corporation Product/Solution Launches and Enhancements Analysis
8.15.4 Synmosa Biopharma Corporation Business Overview/Recent Development/Acquisitions
8.16 Shanghai Sine Promod Pharmaceutical
8.16.1 Shanghai Sine Promod Pharmaceutical Profile
8.16.2 Shanghai Sine Promod Pharmaceutical Sales, Growth Rate and Global Market Share from 2015-2020
8.16.3 Shanghai Sine Promod Pharmaceutical Product/Solution Launches and Enhancements Analysis
8.16.4 Shanghai Sine Promod Pharmaceutical Business Overview/Recent Development/Acquisitions
8.17 Allergan
8.17.1 Allergan Profile
8.17.2 Allergan Sales, Growth Rate and Global Market Share from 2015-2020
8.17.3 Allergan Product/Solution Launches and Enhancements Analysis
8.17.4 Allergan Business Overview/Recent Development/Acquisitions
8.18 Chiesi Farmaceutici
8.18.1 Chiesi Farmaceutici Profile
8.18.2 Chiesi Farmaceutici Sales, Growth Rate and Global Market Share from 2015-2020
8.18.3 Chiesi Farmaceutici Product/Solution Launches and Enhancements Analysis
8.18.4 Chiesi Farmaceutici Business Overview/Recent Development/Acquisitions
8.19 Tillotts Pharma
8.19.1 Tillotts Pharma Profile
8.19.2 Tillotts Pharma Sales, Growth Rate and Global Market Share from 2015-2020
8.19.3 Tillotts Pharma Product/Solution Launches and Enhancements Analysis
8.19.4 Tillotts Pharma Business Overview/Recent Development/Acquisitions
8.20 Abbvie
8.20.1 Abbvie Profile
8.20.2 Abbvie Sales, Growth Rate and Global Market Share from 2015-2020
8.20.3 Abbvie Product/Solution Launches and Enhancements Analysis
8.20.4 Abbvie Business Overview/Recent Development/Acquisitions
8.21 Teva
8.21.1 Teva Profile
8.21.2 Teva Sales, Growth Rate and Global Market Share from 2015-2020
8.21.3 Teva Product/Solution Launches and Enhancements Analysis
8.21.4 Teva Business Overview/Recent Development/Acquisitions
9 Global Mesalamine Market-Segmentation by Geography
10 North America
10.1 North America Mesalamine Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
10.2 North America Mesalamine Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
10.3 North America Mesalamine Production Analysis from 2015-2020
10.4 North America Mesalamine Consumption Analysis from 2015-2020
10.5 North America Mesalamine Import and Export from 2015-2020
10.6 North America Mesalamine Value, Production and Market Share by Type (2015-2020)
10.7 North America Mesalamine Consumption, Value and Market Share by Application (2015-2020)
10.8 North America Mesalamine by Country (United States, Canada)
10.8.1 North America Mesalamine Sales by Country (2015-2020)
10.8.2 North America Mesalamine Consumption Value by Country (2015-2020)
10.9 North America Mesalamine Market PEST Analysis
11 Europe
11.1 Europe Mesalamine Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
11.2 Europe Mesalamine Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
11.3 Europe Mesalamine Production Analysis from 2015-2020
11.4 Europe Mesalamine Consumption Analysis from 2015-2020
11.5 Europe Mesalamine Import and Export from 2015-2020
11.6 Europe Mesalamine Value, Production and Market Share by Type (2015-2020)
11.7 Europe Mesalamine Consumption, Value and Market Share by Application (2015-2020)
11.8 Europe Mesalamine by Country (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden, Poland, Belgium)
11.8.1 Europe Mesalamine Sales by Country (2015-2020)
11.8.2 Europe Mesalamine Consumption Value by Country (2015-2020)
11.9 Europe Mesalamine Market PEST Analysis
12 Asia-Pacific
12.1 Asia-Pacific Mesalamine Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
12.2 Asia-Pacific Mesalamine Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
12.3 Asia-Pacific Mesalamine Production Analysis from 2015-2020
12.4 Asia-Pacific Mesalamine Consumption Analysis from 2015-2020
12.5 Asia-Pacific Mesalamine Import and Export from 2015-2020
12.6 Asia-Pacific Mesalamine Value, Production and Market Share by Type (2015-2020)
12.7 Asia-Pacific Mesalamine Consumption, Value and Market Share by Application (2015-2020)
12.8 Asia-Pacific Mesalamine by Country (China, Japan, South Korea, Australia, India, Taiwan, Indonesia, Thailand, Philippines, Malaysia)
12.8.1 Asia-Pacific Mesalamine Sales by Country (2015-2020)
12.8.2 Asia-Pacific Mesalamine Consumption Value by Country (2015-2020)
12.9 Asia-Pacific Mesalamine Market PEST Analysis
13 Latin America
13.1 Latin America Mesalamine Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
13.2 Latin America Mesalamine Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
13.3 Latin America Mesalamine Production Analysis from 2015-2020
13.4 Latin America Mesalamine Consumption Analysis from 2015-2020
13.5 Latin America Mesalamine Import and Export from 2015-2020
13.6 Latin America Mesalamine Value, Production and Market Share by Type (2015-2020)
13.7 Latin America Mesalamine Consumption, Value and Market Share by Application (2015-2020)
13.8 Latin America Mesalamine by Country (Brazil, Mexico, Argentina, Columbia, Chile)
13.8.1 Latin America Mesalamine Sales by Country (2015-2020)
13.8.2 Latin America Mesalamine Consumption Value by Country (2015-2020)
13.9 Latin America Mesalamine Market PEST Analysis
14 Middle East & Africa
14.1 Middle East & Africa Mesalamine Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
14.2 Middle East & Africa Mesalamine Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
14.3 Middle East & Africa Mesalamine Production Analysis from 2015-2020
14.4 Middle East & Africa Mesalamine Consumption Analysis from 2015-2020
14.5 Middle East & Africa Mesalamine Import and Export from 2015-2020
14.6 Middle East & Africa Mesalamine Value, Production and Market Share by Type (2015-2020)
14.7 Middle East & Africa Mesalamine Consumption, Value and Market Share by Application (2015-2020)
14.8 Middle East & Africa Mesalamine by Country (Saudi Arabia, UAE, Egypt, Nigeria, South Africa)
14.8.1 Middle East & Africa Mesalamine Sales by Country (2015-2020)
14.8.2 Middle East & Africa Mesalamine Consumption Value by Country (2015-2020)
14.9 Middle East & Africa Mesalamine Market PEST Analysis
15 Future Forecast of the Global Mesalamine Market from 2020-2028
15.1 Future Forecast of the Global Mesalamine Market from 2020-2028 Segment by Region
15.2 Global Mesalamine Production and Growth Rate Forecast by Type (2020-2028)
15.3 Global Mesalamine Consumption and Growth Rate Forecast by Application (2020-2028)
16 Appendix
16.1 Methodology
16.2 Research Data Source